Skip to content

A Study to Examine the Effects of Cosmeceutical Therapy in Subjects Undergoing Full Facial Rejuvenation

A Post-Market, Randomized, Placebo-Controlled Study to Assess the Efficacy of Cosmeceutical Therapy in Subjects Undergoing Full Facial Rejuvenation

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02726451
Enrollment
20
Registered
2016-04-01
Start date
2016-03-31
Completion date
2016-12-11
Last updated
2020-10-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Facial Rejuvenation With Neurotoxins and/or Hyaluronic Acid Fillers

Brief summary

The primary objective of this study is to determine the efficacy of Sensi Peel®, Rejuvenating Serum, and the C&E Strength Max skin care products in subjects who undergo full facial rejuvenation, with a botulinum neurotoxin A and/or hyaluronic acid filler, in improving the appearance of the skin, patient satisfaction with aesthetic appearance, and the projected first impressions. The secondary objective of this study is to examine patient satisfaction with the continuous use of Sensi Peel®, Rejuvenating Serum, and the C&E Strength Max products.

Interventions

OTHERBasic Skin Care

Facial Wash, Hydrator Plus Broad Spectrum SPF 30, and Rebalance skin care products (PCA SKIN®)

OTHERActive Skin Care

Sensi Peel®, Rejuvenating Serum, and C&E Strength Max skin care products (PCA SKIN®) in addition to the Facial Wash, Hydrator Plus Broad Spectrum SPF 30, and Rebalance skin care products (PCA SKIN®)

Sponsors

DeNova Research
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
OTHER
Masking
SINGLE (Investigator)

Eligibility

Sex/Gender
FEMALE
Age
21 Years to 60 Years
Healthy volunteers
Yes

Inclusion criteria

* Subject is a female between the ages of 21 and 60; * Subject requires a full facial rejuvenation with a HA soft tissue filler and/or botulinum neurotoxin, per judgment of the PI or designee; * Subject is willing and able to provide written informed consent prior to the performance of any study related procedure; * Subject is willing and able to comply with the protocol requirements; and * Subject is willing and able to provide written photo consent and adhere to the photography and video procedures such as removal of jewelry and makeup.

Exclusion criteria

* Subjects who have received any facial filler in the 12-month or neurotoxin treatments in the 4-month period prior to enrollment; * Previous treatment with any resurfacing facial aesthetic procedure (e.g. deep chemical peeling and laser treatments) within the 12-month period prior to enrollment; * Previous treatment with photo rejuvenation therapy within the 6-month period prior to enrollment; * Subjects who plan to undergo facial cosmetic surgery or any aesthetic procedure (e.g. neurotoxins, dermal fillers, laser treatments, and chemical peels), which are not specified in this protocol, during the course of the study; * A known allergy or sensitivity to any component of the study ingredients; * Use of systemic steroids or anticoagulation medications; * Subjects with a history of bleeding disorders; * Subjects with severe allergies manifested by a history of anaphylaxis or presence of multiple severe allergies; * Subjects with hypersensitivity to botulinum neurotoxin; * Subject with allergies to gram positive bacterial proteins; * Sensitivity to sulfides; * Subjects with allergy to cow's milk protein; * Subjects with previous history of sensitivity to amide type local anesthetics; * Subject with surgical alterations to the facial anatomy or marked facial asymmetry; * Inflammation or infection at the injection site(s); * Subjects with a history of eyelid or eyebrow ptosis; * Excessive dermatochalasis, deep dermal scarring, or thick sebaceous skin; * Subjects with neuromuscular disorders; * Use of anticholinergic, aminoglycosides or other agents that interfere with neuromuscular transmission (e.g., curare-like agents), or muscle relaxants; * Subjects with immunodeficiencies such as HIV, lupus, scleroderma, and systemic infections; * Pregnant, nursing, or sexually active female subjects who are of childbearing potential and who are not willing to use an acceptable form of contraception (e.g., barrier methods used with a spermicidal agent, hormonal methods, IUD, surgical sterilization, abstinence); * Current history of chronic drug or alcohol abuse; * Concurrent therapy that, in the investigator's opinion, would interfere with the evaluation of the safety or efficacy of the study product; * Subjects who, in the investigator's opinion, have a history of poor cooperation, non-compliance with medical treatment, or unreliability; and * Enrollment in any active study involving the use of investigational devices or drugs.

Design outcomes

Primary

MeasureTime frameDescription
C-GAIS by the PI or DesigneeApproximately 3 months from the baseline visitGlobal aesthetic improvement in subjects is assessed by the PI/designee using the Global Aesthetic Improvement Scale (C-GAIS). Clinical-Global Aesthetic Improvement Scale (C-GAIS): 3 (Very Much Improved) 2 (Much Improved) 1 (Improved) 0 (No change) -1 (Worse) Scores closer to 3 show a more favorable outcome Scores closer to -1 show a less favorable outcome
SQA by the PI or DesigneeApproximately 3 months from the baseline visitThe quality of subjects' skin is assessed by PI/designee using the Skin Quality Assessment (SQA) Skin Quality Assessment (SQA): Tone (dyschromia) 0 - severe unevenness 1- moderate to severe unevenness 2 - moderate unevenness 3 - mild unevenness 4 - even Elasticity (Firmness) 0 - Very poor elasticity 1. \- poor elasticity 2. \- fair elasticity 3. \- good elasticity 4. \- firm Texture (Smoothness) 0 - severe 1. \- moderate to severe 2. \- moderate 3. \- mild 4. \- none Radiance 0 - severe dullness 1. \- moderate to severe dullness 2. \- moderate dullness 3. \- mild dullness 4. \- radiant All scores with a higher number indicate favorable results All scores with a lower number indicate less favorable results

Secondary

MeasureTime frameDescription
Face-Q by SubjectsFinal assessment is approximately 3 months from the baseline visitSubjects self-evaluation of their quality of skin, age-appraisal, and social and psychological assessments are performed using the Face-Q questionnaire. FACE-Q (Satisfaction with Skin): scored between 1-4 for 12 questions. Total score closer to 48 indicates a more favorable outcome FACE-Q (Satisfaction with Facial Appearance Overall): scored between 1-4 for 10 questions. Total score closer to 40 indicates a more favorable outcome FACE-Q (Aging Appearance Appraisal): scored between 1-4 for 7 questions. Total score closer to 28 indicates a more favorable outcome FACE-Q (Age Appraisal-VAS): scored between -15 to +15. Total score closer to -15 indicates a more favorable outcome FACE-Q (Psychological Well-Being): scored between 1-4 for 10 questions. Total score closer to 40 indicates a more favorable outcome FACE-Q (Social Function):scored between 1-4 for 8 questions. Total score closer to 32 indicates a more favorable outcome
SSES by SubjectsFinal assessment is approximately 3 months from the baseline visitChanges in self-esteem is assessed using the State Self-Esteem Scale (SSES): performance, social, and appearance State Self-Esteem Scale (SSES): scored between 1-5 for 20 questions. Scores closer to 100 indicate a more favorable outcome
FIQ by Blinded EvaluatorsAt the conclusion of study assessments (approximately 3 months from the baseline visit)The projected first impressions are assessed by blinded evaluators using the First Impression Questionnaire (FIQ). First Impression Questionnaire (FIQ): scored between 1-10 for 8 questions. Scores closer to 10 for each question indicate a more favorable outcome

Countries

United States

Participant flow

Participants by arm

ArmCount
Basic Skin Care
Subjects use a basic skin care regimen. Basic Skin Care: Facial Wash, Hydrator Plus Broad Spectrum SPF 30, and Rebalance skin care products (PCA SKIN®)
10
Active Skin Care
Subjects use the Sensi Peel®, Rejuvenating Serum, and C&E Strength Max skin care products in additional to a basic skin care regiment. Active Skin Care: Sensi Peel®, Rejuvenating Serum, and C&E Strength Max skin care products (PCA SKIN®) in addition to the Facial Wash, Hydrator Plus Broad Spectrum SPF 30, and Rebalance skin care products (PCA SKIN®)
10
Total20

Baseline characteristics

CharacteristicActive Skin CareBasic Skin CareTotal
Age, Categorical
<=18 years
0 Participants0 Participants0 Participants
Age, Categorical
>=65 years
3 Participants2 Participants5 Participants
Age, Categorical
Between 18 and 65 years
7 Participants8 Participants15 Participants
Age, Continuous54.3 years54.3 years54.3 years
Region of Enrollment
United States
10 participants10 participants20 participants
Sex: Female, Male
Female
10 Participants10 Participants20 Participants
Sex: Female, Male
Male
0 Participants0 Participants0 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
0 / 100 / 10
other
Total, other adverse events
0 / 100 / 10
serious
Total, serious adverse events
0 / 100 / 10

Outcome results

Primary

C-GAIS by the PI or Designee

Global aesthetic improvement in subjects is assessed by the PI/designee using the Global Aesthetic Improvement Scale (C-GAIS). Clinical-Global Aesthetic Improvement Scale (C-GAIS): 3 (Very Much Improved) 2 (Much Improved) 1 (Improved) 0 (No change) -1 (Worse) Scores closer to 3 show a more favorable outcome Scores closer to -1 show a less favorable outcome

Time frame: Approximately 3 months from the baseline visit

ArmMeasureGroupValue (MEAN)Dispersion
Basic Skin CareC-GAIS by the PI or DesigneeVisit 71.22 units on a scaleStandard Deviation 0.441
Basic Skin CareC-GAIS by the PI or DesigneeVisit 8/91.75 units on a scaleStandard Deviation 0.886
Active Skin CareC-GAIS by the PI or DesigneeVisit 72.13 units on a scaleStandard Deviation 0.835
Active Skin CareC-GAIS by the PI or DesigneeVisit 8/92.75 units on a scaleStandard Deviation 0.787
Primary

SQA by the PI or Designee

The quality of subjects' skin is assessed by PI/designee using the Skin Quality Assessment (SQA) Skin Quality Assessment (SQA): Tone (dyschromia) 0 - severe unevenness 1- moderate to severe unevenness 2 - moderate unevenness 3 - mild unevenness 4 - even Elasticity (Firmness) 0 - Very poor elasticity 1. \- poor elasticity 2. \- fair elasticity 3. \- good elasticity 4. \- firm Texture (Smoothness) 0 - severe 1. \- moderate to severe 2. \- moderate 3. \- mild 4. \- none Radiance 0 - severe dullness 1. \- moderate to severe dullness 2. \- moderate dullness 3. \- mild dullness 4. \- radiant All scores with a higher number indicate favorable results All scores with a lower number indicate less favorable results

Time frame: Approximately 3 months from the baseline visit

ArmMeasureGroupValue (MEAN)Dispersion
Basic Skin CareSQA by the PI or DesigneeTone - Visit 11.44 units on a scaleStandard Deviation 0.527
Basic Skin CareSQA by the PI or DesigneeTone - Visit 71.78 units on a scaleStandard Deviation 0.667
Basic Skin CareSQA by the PI or DesigneeTone - Visit 8/92.88 units on a scaleStandard Deviation 0.641
Basic Skin CareSQA by the PI or DesigneeElasticity - Visit 11.33 units on a scaleStandard Deviation 0.5
Basic Skin CareSQA by the PI or DesigneeElasticity - Visit 72.33 units on a scaleStandard Deviation 0.5
Basic Skin CareSQA by the PI or DesigneeElasticity - Visit 8/92.75 units on a scaleStandard Deviation 0.707
Basic Skin CareSQA by the PI or DesigneeTexture - Visit 11.11 units on a scaleStandard Deviation 0.601
Basic Skin CareSQA by the PI or DesigneeTexture - Visit 72.33 units on a scaleStandard Deviation 0.5
Basic Skin CareSQA by the PI or DesigneeTexture - Visit 8/92.88 units on a scaleStandard Deviation 0.835
Basic Skin CareSQA by the PI or DesigneeRadiance - Visit 10.88 units on a scaleStandard Deviation 0.354
Basic Skin CareSQA by the PI or DesigneeRadiance - Visit 72.25 units on a scaleStandard Deviation 0.707
Basic Skin CareSQA by the PI or DesigneeRadiance - Visit 8/93.00 units on a scaleStandard Deviation 0.926
Active Skin CareSQA by the PI or DesigneeRadiance - Visit 73.25 units on a scaleStandard Deviation 0.886
Active Skin CareSQA by the PI or DesigneeTone - Visit 11.20 units on a scaleStandard Deviation 0.422
Active Skin CareSQA by the PI or DesigneeTexture - Visit 11.10 units on a scaleStandard Deviation 0.316
Active Skin CareSQA by the PI or DesigneeTone - Visit 72.75 units on a scaleStandard Deviation 0.707
Active Skin CareSQA by the PI or DesigneeRadiance - Visit 11.0 units on a scaleStandard Deviation 0
Active Skin CareSQA by the PI or DesigneeTone - Visit 8/93.14 units on a scaleStandard Deviation 0.69
Active Skin CareSQA by the PI or DesigneeTexture - Visit 73.25 units on a scaleStandard Deviation 0.886
Active Skin CareSQA by the PI or DesigneeElasticity - Visit 11.30 units on a scaleStandard Deviation 0.483
Active Skin CareSQA by the PI or DesigneeRadiance - Visit 8/93.71 units on a scaleStandard Deviation 0.488
Active Skin CareSQA by the PI or DesigneeElasticity - Visit 73.25 units on a scaleStandard Deviation 0.886
Active Skin CareSQA by the PI or DesigneeTexture - Visit 8/93.71 units on a scaleStandard Deviation 0.488
Active Skin CareSQA by the PI or DesigneeElasticity - Visit 8/93.57 units on a scaleStandard Deviation 0.535
Secondary

Face-Q by Subjects

Subjects self-evaluation of their quality of skin, age-appraisal, and social and psychological assessments are performed using the Face-Q questionnaire. FACE-Q (Satisfaction with Skin): scored between 1-4 for 12 questions. Total score closer to 48 indicates a more favorable outcome FACE-Q (Satisfaction with Facial Appearance Overall): scored between 1-4 for 10 questions. Total score closer to 40 indicates a more favorable outcome FACE-Q (Aging Appearance Appraisal): scored between 1-4 for 7 questions. Total score closer to 28 indicates a more favorable outcome FACE-Q (Age Appraisal-VAS): scored between -15 to +15. Total score closer to -15 indicates a more favorable outcome FACE-Q (Psychological Well-Being): scored between 1-4 for 10 questions. Total score closer to 40 indicates a more favorable outcome FACE-Q (Social Function):scored between 1-4 for 8 questions. Total score closer to 32 indicates a more favorable outcome

Time frame: Final assessment is approximately 3 months from the baseline visit

ArmMeasureGroupValue (MEAN)Dispersion
Basic Skin CareFace-Q by SubjectsAging Appearance Appraisal - V8/91.45 units on a scaleStandard Deviation 0.835
Basic Skin CareFace-Q by SubjectsSatisfaction with Skin - V73.27 units on a scaleStandard Deviation 0.667
Basic Skin CareFace-Q by SubjectsAge Appraisal-VAS - V5-2 units on a scaleStandard Deviation 0.354
Basic Skin CareFace-Q by SubjectsSatisfaction with Facial Appearance Overall - V73.08 units on a scaleStandard Deviation 0.5
Basic Skin CareFace-Q by SubjectsAge Appraisal-VAS - V7-2.22 units on a scaleStandard Deviation 0.707
Basic Skin CareFace-Q by SubjectsSatisfaction with Skin - V53.21 units on a scaleStandard Deviation 0.88
Basic Skin CareFace-Q by SubjectsAge Appraisal-VAS - V8/9-5.38 units on a scaleStandard Deviation 0.926
Basic Skin CareFace-Q by SubjectsSatisfaction with Facial Appearance Overall - V8/93.46 units on a scaleStandard Deviation 0.707
Basic Skin CareFace-Q by SubjectsPsychological Well-Being - V73.52 units on a scaleStandard Deviation 0.552
Basic Skin CareFace-Q by SubjectsSatisfaction with Skin - V8/93.6 units on a scaleStandard Deviation 0.641
Basic Skin CareFace-Q by SubjectsPsychological Well-Being - V8/93.81 units on a scaleStandard Deviation 0.699
Basic Skin CareFace-Q by SubjectsAging Appearance Appraisal - V52.22 units on a scaleStandard Deviation 0.601
Basic Skin CareFace-Q by SubjectsSocial Function - V53.51 units on a scaleStandard Deviation 0.553
Basic Skin CareFace-Q by SubjectsPsychological Well-Being - V53.5 units on a scaleStandard Deviation 0.568
Basic Skin CareFace-Q by SubjectsSocial Function - V73.56 units on a scaleStandard Deviation 0.878
Basic Skin CareFace-Q by SubjectsAging Appearance Appraisal - V72.08 units on a scaleStandard Deviation 0.5
Basic Skin CareFace-Q by SubjectsSocial Function - V8/93.67 units on a scaleStandard Deviation 0.787
Basic Skin CareFace-Q by SubjectsSatisfaction with Facial Appearance Overall - V53.14 units on a scaleStandard Deviation 0.5
Active Skin CareFace-Q by SubjectsSocial Function - V8/93.57 units on a scaleStandard Deviation 0.477
Active Skin CareFace-Q by SubjectsSatisfaction with Skin - V53.54 units on a scaleStandard Deviation 0.778
Active Skin CareFace-Q by SubjectsSatisfaction with Skin - V73.29 units on a scaleStandard Deviation 0.787
Active Skin CareFace-Q by SubjectsSatisfaction with Skin - V8/93.18 units on a scaleStandard Deviation 0.69
Active Skin CareFace-Q by SubjectsSatisfaction with Facial Appearance Overall - V53.13 units on a scaleStandard Deviation 0.483
Active Skin CareFace-Q by SubjectsSatisfaction with Facial Appearance Overall - V73.06 units on a scaleStandard Deviation 0.886
Active Skin CareFace-Q by SubjectsSatisfaction with Facial Appearance Overall - V8/93.1 units on a scaleStandard Deviation 0.535
Active Skin CareFace-Q by SubjectsAging Appearance Appraisal - V51.79 units on a scaleStandard Deviation 0.316
Active Skin CareFace-Q by SubjectsAging Appearance Appraisal - V71.88 units on a scaleStandard Deviation 0.886
Active Skin CareFace-Q by SubjectsAging Appearance Appraisal - V8/91.61 units on a scaleStandard Deviation 0.488
Active Skin CareFace-Q by SubjectsAge Appraisal-VAS - V5-3 units on a scaleStandard Deviation 0.5
Active Skin CareFace-Q by SubjectsAge Appraisal-VAS - V7-3.13 units on a scaleStandard Deviation 0.886
Active Skin CareFace-Q by SubjectsAge Appraisal-VAS - V8/9-3.57 units on a scaleStandard Deviation 0.488
Active Skin CareFace-Q by SubjectsPsychological Well-Being - V73.66 units on a scaleStandard Deviation 0.59
Active Skin CareFace-Q by SubjectsPsychological Well-Being - V8/93.8 units on a scaleStandard Deviation 0.658
Active Skin CareFace-Q by SubjectsSocial Function - V53.53 units on a scaleStandard Deviation 0.633
Active Skin CareFace-Q by SubjectsSocial Function - V73.58 units on a scaleStandard Deviation 0.925
Active Skin CareFace-Q by SubjectsPsychological Well-Being - V53.54 units on a scaleStandard Deviation 0.526
Secondary

FIQ by Blinded Evaluators

The projected first impressions are assessed by blinded evaluators using the First Impression Questionnaire (FIQ). First Impression Questionnaire (FIQ): scored between 1-10 for 8 questions. Scores closer to 10 for each question indicate a more favorable outcome

Time frame: At the conclusion of study assessments (approximately 3 months from the baseline visit)

ArmMeasureGroupValue (MEAN)Dispersion
Basic Skin CareFIQ by Blinded EvaluatorsSocial skills - Before4.9525 units on a scaleStandard Deviation 0.79094
Basic Skin CareFIQ by Blinded EvaluatorsSocial skills - After5.9136 units on a scaleStandard Deviation 0.6401
Basic Skin CareFIQ by Blinded EvaluatorsAcademic Performance - Before5.3400 units on a scaleStandard Deviation 0.83351
Basic Skin CareFIQ by Blinded EvaluatorsAcademic Performance - After6.1550 units on a scaleStandard Deviation 0.48823
Basic Skin CareFIQ by Blinded EvaluatorsDating success - Before4.6700 units on a scaleStandard Deviation 1.21824
Basic Skin CareFIQ by Blinded EvaluatorsDating success - After5.5470 units on a scaleStandard Deviation 0.85017
Basic Skin CareFIQ by Blinded EvaluatorsOccupational success - Before5.3350 units on a scaleStandard Deviation 0.93159
Basic Skin CareFIQ by Blinded EvaluatorsOccupational success - After6.0723 units on a scaleStandard Deviation 0.57428
Basic Skin CareFIQ by Blinded EvaluatorsAttractiveness - Before4.7225 units on a scaleStandard Deviation 1.27725
Basic Skin CareFIQ by Blinded EvaluatorsAttractiveness - After5.7758 units on a scaleStandard Deviation 1.03805
Basic Skin CareFIQ by Blinded EvaluatorsFinancial Success - Before5.3025 units on a scaleStandard Deviation 0.92139
Basic Skin CareFIQ by Blinded EvaluatorsFinancial Success - After6.0309 units on a scaleStandard Deviation 0.61463
Basic Skin CareFIQ by Blinded EvaluatorsRelationship success - Before5.0850 units on a scaleStandard Deviation 0.96094
Basic Skin CareFIQ by Blinded EvaluatorsRelationship success - After5.9597 units on a scaleStandard Deviation 0.69371
Basic Skin CareFIQ by Blinded EvaluatorsAthletic success - Before4.6475 units on a scaleStandard Deviation 1.31627
Basic Skin CareFIQ by Blinded EvaluatorsAthletic success - After5.4897 units on a scaleStandard Deviation 0.9688
Active Skin CareFIQ by Blinded EvaluatorsAthletic success - After5.7467 units on a scaleStandard Deviation 1.67741
Active Skin CareFIQ by Blinded EvaluatorsSocial skills - Before5.0600 units on a scaleStandard Deviation 0.83857
Active Skin CareFIQ by Blinded EvaluatorsAttractiveness - Before4.9467 units on a scaleStandard Deviation 1.07574
Active Skin CareFIQ by Blinded EvaluatorsSocial skills - After6.3333 units on a scaleStandard Deviation 1.67975
Active Skin CareFIQ by Blinded EvaluatorsRelationship success - Before5.2167 units on a scaleStandard Deviation 0.76078
Active Skin CareFIQ by Blinded EvaluatorsAcademic Performance - Before5.3900 units on a scaleStandard Deviation 0.78095
Active Skin CareFIQ by Blinded EvaluatorsAttractiveness - After6.0867 units on a scaleStandard Deviation 1.9509
Active Skin CareFIQ by Blinded EvaluatorsAcademic Performance - After6.2800 units on a scaleStandard Deviation 1.63815
Active Skin CareFIQ by Blinded EvaluatorsAthletic success - Before4.6767 units on a scaleStandard Deviation 1.03115
Active Skin CareFIQ by Blinded EvaluatorsDating success - Before5.0367 units on a scaleStandard Deviation 0.99995
Active Skin CareFIQ by Blinded EvaluatorsFinancial Success - Before5.3567 units on a scaleStandard Deviation 0.81363
Active Skin CareFIQ by Blinded EvaluatorsDating success - After6.1433 units on a scaleStandard Deviation 1.85263
Active Skin CareFIQ by Blinded EvaluatorsRelationship success - After6.3233 units on a scaleStandard Deviation 1.70127
Active Skin CareFIQ by Blinded EvaluatorsOccupational success - Before5.5233 units on a scaleStandard Deviation 0.77835
Active Skin CareFIQ by Blinded EvaluatorsFinancial Success - After6.2467 units on a scaleStandard Deviation 1.58249
Active Skin CareFIQ by Blinded EvaluatorsOccupational success - After6.3967 units on a scaleStandard Deviation 1.58576
Secondary

SSES by Subjects

Changes in self-esteem is assessed using the State Self-Esteem Scale (SSES): performance, social, and appearance State Self-Esteem Scale (SSES): scored between 1-5 for 20 questions. Scores closer to 100 indicate a more favorable outcome

Time frame: Final assessment is approximately 3 months from the baseline visit

ArmMeasureGroupValue (MEAN)Dispersion
Basic Skin CareSSES by SubjectsBaseline80.5 units on a scaleStandard Deviation 0.527
Basic Skin CareSSES by SubjectsVisit 779 units on a scaleStandard Deviation 0.886
Basic Skin CareSSES by SubjectsVisit 8/984 units on a scaleStandard Deviation 0.641
Active Skin CareSSES by SubjectsBaseline78.5 units on a scaleStandard Deviation 0.422
Active Skin CareSSES by SubjectsVisit 780 units on a scaleStandard Deviation 0.707
Active Skin CareSSES by SubjectsVisit 8/985 units on a scaleStandard Deviation 0.69

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026